Overall, our assessments of patient survival performed on a variety of platforms, such as R2, Oncomine, and PrognoScan, highlighted the oncogenic significance of PHLDA1 in brain and pancreatic cancer. The gene discussed is PHLDA1; the disease is pancreatic neoplasm.